Marshall Wace
ASLN

Marshall Wace’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Marshall Wace’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,402
Closed -$195K – 2149
2019
Q4 		$195K Buy
+2,402
New +$172K ﹤0.01% 1350

Other funds holding ASLN

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Marshall Wace's ASLN Position: Q1 2020 in Review

Marshall Wace sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2020, closing a stake of 2,402 shares — an estimated $195K sold.

Marshall Wace first reported a position in ASLN in Q4 2019 and held it in 1 quarter. The position peaked at $195K in Q4 2019. 11 funds tracked by Wall St. Rank hold ASLN as of Q1 2020.

  • Marshall Wace reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace sold 2,402 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2020, an estimated $195K.
  • Marshall Wace first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 1 quarter.
  • Marshall Wace's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $195K in Q4 2019.
  • 11 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2020.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.